Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis

Ann Rheum Dis. 2010 Mar;69(3):624-5. doi: 10.1136/ard.2009.108787.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / blood
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / blood
  • Antirheumatic Agents / immunology
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / blood
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / immunology
  • Dose-Response Relationship, Immunologic
  • Female
  • Humans
  • Male
  • Middle Aged
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab